---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-132569"
form_type: "8-K"
ticker: "NVAX"
cik: "0001000694"
company_name: "NOVAVAX INC"
filed_at: "2024-12-30T23:59:59+00:00"
generated_at: "2026-05-28T22:36:38.651367+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Novavax completes $200M sale of Czech manufacturing campus to Novo Nordisk

## Summary
- Total purchase price $200M; $180M cash at close, $10M paid Sept 2024, $10M escrow for 12 months.
- Seller also received ~$2.6M reimbursement for operating costs between Dec 3 and closing.
- Novavax sold its Bohumil, Jevany facility including land, movable assets, contracts, and employees.
- Transaction closed Dec 30, 2024; Novo Nordisk Production Czech s.r.o. is the purchaser.

## SEC filing metadata
- accession: 0001104659-24-132569
- form_type: 8-K
- ticker: NVAX
- cik: 0001000694
- company_name: NOVAVAX INC
- filed_at: 2024-12-30T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000694/000110465924132569/0001104659-24-132569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000694/000110465924132569/tm2432218d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-132569
- JSON: https://secwatch.observer/filing/0001104659-24-132569.json
- Plain text: https://secwatch.observer/filing/0001104659-24-132569.txt

## Key facts
- M&A Transactions
  NOVAVAX INC completed a disposition involving Novo Nordisk Production Czech s.r.o. for $200 million and the assumption by the Purchaser of liabilities (closed 2024-12-30).
  - Action: disposition
  - Counterparty: Novo Nordisk Production Czech s.r.o.
  - Consideration: $200 million and the assumption by the Purchaser of liabilities
  - Closing: 2024-12-30
  source text: (iii) certain employees currently providing services related to the Transferred Assets (the “Transferred Employees”). The total purchase price for the Facility was $200 million and the assumption by the Purchaser of liabilities (on a look-forward basis) pertaining to the Transferred Assets, Transferred Contracts and Transferred Employees. On the closing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465924132569/0001104659-24-132569-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.